Lilja; Hans
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lilja; Hans.The latest application filed is for "methods and apparatuses for predicting risk of prostate cancer and prostate gland volume".
- Lilja; Hans - New York NY
- Lilja; Hans - Skanor SE
- Lilja; Hans - S-239 35 Skanor SE
- Lilja, Hans - Skannor SE
- Lilja; Hans - 236 34 Hollviken SE
| Patent | Date |
|---|---|
| Methods and apparatuses for conducting analyses Grant 10,672,503 - Vickers , et al. | 2020-06-02 |
| Methods And Apparatuses For Predicting Risk Of Prostate Cancer And Prostate Gland Volume App 20170168060 - Vickers; Andrew J. ; et al. | 2017-06-15 |
| Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume Grant 9,672,329 - Vickers , et al. June 6, 2 | 2017-06-06 |
| Compositions And Methods For Active Surveillance Of Prostate Cancer App 20170089904 - Dong; Yan ; et al. | 2017-03-30 |
| Methods And Apparatuses For Conducting Analyses App 20170091380 - Vickers; Andrew J. ; et al. | 2017-03-30 |
| Methods And Apparatuses For Conducting Analyses App 20170091379 - Vickers; Andrew J. ; et al. | 2017-03-30 |
| Compositions And Methods For Active Surveillance Of Prostate Cancer App 20160320394 - DONG; YAN ; et al. | 2016-11-03 |
| Compositions And Methods Related To Diagnosis Of Prostate Cancer App 20160025732 - Linder; Vincent ; et al. | 2016-01-28 |
| Activation of peptide prodrugs by hK2 Grant 8,669,231 - Denmeade , et al. March 11, 2 | 2014-03-11 |
| Activation of peptide prodrugs by hK2 Grant 8,450,280 - Denmeade , et al. May 28, 2 | 2013-05-28 |
| Activation of Peptide Prodrugs by hK2 App 20120309692 - Denmeade; Samuel R. ; et al. | 2012-12-06 |
| Activation of Peptide Prodrugs by HK2 App 20110245147 - Denmeade; Samuel R. ; et al. | 2011-10-06 |
| Activation of peptide prodrugs by hK2 Grant 7,906,477 - Denmeade , et al. March 15, 2 | 2011-03-15 |
| Antibody, immunoassay and method for prostate cancer detection Grant 7,872,104 - Pettersson , et al. January 18, 2 | 2011-01-18 |
| Activation of peptide prodrugs by hK2 App 20080247950 - Denmeade; Samuel R. ; et al. | 2008-10-09 |
| Activation of peptide prodrugs by hk2 App 20060217317 - Denmeade; Samuel R. ; et al. | 2006-09-28 |
| Activation of peptide prodrugs by hK2 App 20060183689 - Denmeade; Samuel R. ; et al. | 2006-08-17 |
| Activation of peptide prodrugs by hK2 Grant 7,053,042 - Denmeade , et al. May 30, 2 | 2006-05-30 |
| Novel antibody, immunoassay and method for prostate cancer detection App 20040101914 - Pettersson, Kim ; et al. | 2004-05-27 |
| Tissue specific prodrug Grant 6,504,014 - Isaacs , et al. January 7, 2 | 2003-01-07 |
| Prostate specific antigen (PSA) -proteinase inhibitors complexes App 20020123616 - Lilja, Hans ; et al. | 2002-09-05 |
| Tissue specific prodrug Grant 6,265,540 - Isaacs , et al. July 24, 2 | 2001-07-24 |
| Early detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1) Grant 5,614,372 - Lilja , et al. March 25, 1 | 1997-03-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 